Pfizer Inc. (PFE) financials
Healthcare · CIK 0000078003 · fiscal years FY2021–FY2025
In fiscal year 2025 (ending Dec 2025), Pfizer Inc. (PFE) reported $62.58B in revenue and $7.77B in net income, a net profit margin of 12.4%. Revenue changed −1.6% versus FY2024. Over FY2021–FY2025, revenue grew at a −6.3% compound annual rate. All figures are from Pfizer Inc.'s SEC 10-K filings.
Source: SEC EDGAR, CIK 0000078003. Data as of 2026-06-18.
Key ratios (FY2025)
| Metric | Value | Basis |
|---|---|---|
| Net profit margin | 12.4% | Net income ÷ revenue |
| Operating margin | — | Operating income ÷ revenue |
| R&D intensity | — | R&D expense ÷ revenue |
| Revenue YoY growth | −1.6% | vs FY2024 |
| Revenue CAGR (4y) | −6.3% | FY2021 → FY2025 |
Source: SEC EDGAR. Data as of 2026-06-18.
Annual financials by fiscal year
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $81.29B | $91.79B | $50.91B | $63.63B | $62.58B |
| Net income | $21.98B | $31.37B | $2.12B | $8.03B | $7.77B |
| Operating income | — | — | — | — | — |
| R&D expense | — | — | — | — | — |
| Total assets | $181.48B | $197.21B | $226.50B | $213.40B | $208.16B |
| Total liabilities | $104.01B | $101.29B | $137.21B | $124.90B | $121.39B |
| Shareholders' equity | $77.20B | $95.66B | $89.01B | $88.20B | $86.48B |
| Cash & equivalents | $1.94B | $416.0M | $2.85B | $1.04B | $1.14B |
| Diluted EPS | 3.85 | 5.47 | 0.37 | 1.41 | 1.36 |
| Revenue YoY growth | — | +12.9% | −44.5% | +25.0% | −1.6% |
Source: SEC EDGAR — Pfizer Inc. 10-K filings (CIK 0000078003). Data as of 2026-06-18. Revenue concept: RevenueFromContractWithCustomerExcludingAssessedTax + Revenues.
How to read these figures
Revenue is the top line; operating income is profit from core operations before interest and tax; net income is the bottom line after every expense. The profit-margin calculator turns these into margins, and the revenue CAGR calculator annualises multi-year growth. For background, see revenue vs operating income vs net income and how to read a 10-K.
Frequently asked questions
What was Pfizer Inc.'s revenue in FY2025?
Pfizer Inc. reported $62.58B in revenue for fiscal year 2025 (period ending Dec 2025), per its SEC 10-K filing. That is −1.6% versus FY2024.
What is Pfizer Inc.'s net profit margin?
In FY2025, Pfizer Inc. earned $7.77B of net income on $62.58B of revenue — a net profit margin of 12.4%.
How fast has Pfizer Inc.'s revenue grown?
Between FY2021 and FY2025, Pfizer Inc.'s revenue grew at a compound annual rate (CAGR) of −6.3%.
Where does this Pfizer Inc. financial data come from?
All figures are taken from Pfizer Inc.'s annual 10-K filings on SEC EDGAR (CIK 0000078003), via the SEC XBRL company facts API. They are factual data, not investment advice — verify on SEC EDGAR before relying on them.
Source & verification
Figures are taken from Pfizer Inc.'s annual 10-K filings on SEC EDGAR (CIK 0000078003), via the EDGAR XBRL company facts API. They are factual data compiled from SEC filings — not investment advice; figures may contain errors or lag the original filing. Verify on SEC EDGAR before relying on them.
Last updated: 2026-06-18